U.S. House Widens Inquiry of J&J's 'Phantom Recall'

The Johnson & Johnson (NYSE: JNJ) recall probe is unfolding right before our eyes. Today, Congress has requested information from two contractors hired by J&J to buy potentially defective Motrin tablets several months prior to an official recall of the drug back in 2009.

The two companies--WIS International and Inmar--are key to the House Oversight and Government Reform Committee investigation, because some evidence shows that they were buying up the Motrin packets to help J&J avoid an official recall.